SIC 8071 – Medical Laboratories
| Valuation | |
|---|---|
| Market Cap ($M) | n/a |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 5.13 |
| Book Value / Share | 0.84 |
| Price / Book | n/a |
| NCAV ($M) | 1.75 |
| NCAV / Share | 0.29 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.29 |
| Return on Assets (ROA) | -0.17 |
| Return on Equity (ROE) | -0.30 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.82 |
| Current Ratio | 1.82 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.94 |
| Assets | 8.32 |
| Liabilities | 3.19 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 19.68 |
| Operating Income | -1.89 |
| Net Income | -1.86 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.93 |
| Cash from Investing | -0.09 |
| Cash from Financing | -1.39 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Similar Companies | |
|---|---|
| MEDD – Medical Imaging Corp. | OPGN – OpGen, Inc. |
| PCHM – PharmChem, Inc. | RENXF – Renalytix Plc |
Financial data and stock pages provided by
Fintel.io